ADSCs boost the M2-polarizing IL-6 secretion when situated in an inflammatory environment of TGF-β1, explaining the therapeutic mechanism of dialysis-induced peritoneal fibrosis. The gene discussed is IL6; the disease is Peritoneal Fibrosis.